UA35656C2 - Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань - Google Patents
Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворюваньInfo
- Publication number
- UA35656C2 UA35656C2 UA99127123A UA99127123A UA35656C2 UA 35656 C2 UA35656 C2 UA 35656C2 UA 99127123 A UA99127123 A UA 99127123A UA 99127123 A UA99127123 A UA 99127123A UA 35656 C2 UA35656 C2 UA 35656C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dementia
- diseases leading
- continuously progressive
- treating
- psychic diseases
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Винахід відноситься до галузі медицини, а саме - до психоневрології, може бути використаний для лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань (БПОПЗ), наприклад, шизофренії та хвороби Альцгеймера, сенильної деменції Альцгеймерівського типу, хвороби Німана Пика та ін. Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань, що полягає у введенні хворому плазми крові, причому як плазму крові використовують генетично-детерміновану плазму, причому вводять її внутрівенно та/або внутрішньом’язово, а курс лікування визначають по досягненню стійкого усунення патологічних реакцій та по відновленню втрачених навиків.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99127123A UA35656C2 (uk) | 1999-12-27 | 1999-12-27 | Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA99127123A UA35656C2 (uk) | 1999-12-27 | 1999-12-27 | Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA35656C2 true UA35656C2 (uk) | 2001-04-16 |
Family
ID=74181655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA99127123A UA35656C2 (uk) | 1999-12-27 | 1999-12-27 | Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA35656C2 (uk) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245285B2 (en) | 2016-04-28 | 2019-04-02 | Alkahest, Inc. | Blood plasma and plasma fractions as therapy for tumor growth and progression |
| US10357513B2 (en) | 2017-04-26 | 2019-07-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
| US10617744B2 (en) | 2015-06-15 | 2020-04-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
| US10688130B2 (en) | 2013-12-09 | 2020-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| US10688154B2 (en) | 2011-04-08 | 2020-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
| US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11103530B2 (en) | 2018-10-26 | 2021-08-31 | Alkahest, Inc. | Methods of improving or accelerating postoperative recovery |
| US11236340B2 (en) | 2010-01-28 | 2022-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3) |
-
1999
- 1999-12-27 UA UA99127123A patent/UA35656C2/uk unknown
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11912998B2 (en) | 2010-01-28 | 2024-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating aging-associated cognitive impairment by reducing CCR3 |
| US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
| US11236340B2 (en) | 2010-01-28 | 2022-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3) |
| US10626399B2 (en) | 2010-01-28 | 2020-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3) |
| US10688154B2 (en) | 2011-04-08 | 2020-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
| US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
| US10688130B2 (en) | 2013-12-09 | 2020-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| US11141469B2 (en) | 2015-06-15 | 2021-10-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| US10617744B2 (en) | 2015-06-15 | 2020-04-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated conditions |
| US10905717B2 (en) | 2016-04-28 | 2021-02-02 | Alkahest, Inc. | Blood plasma and plasma fractions as therapy for tumor growth and progression |
| US10245285B2 (en) | 2016-04-28 | 2019-04-02 | Alkahest, Inc. | Blood plasma and plasma fractions as therapy for tumor growth and progression |
| US10874692B2 (en) | 2017-04-26 | 2020-12-29 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11413308B2 (en) | 2017-04-26 | 2022-08-16 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US10357513B2 (en) | 2017-04-26 | 2019-07-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11103530B2 (en) | 2018-10-26 | 2021-08-31 | Alkahest, Inc. | Methods of improving or accelerating postoperative recovery |
| US11298377B2 (en) | 2018-10-26 | 2022-04-12 | Alkahest, Inc. | Methods of improving wound healing |
| US11547724B2 (en) | 2018-10-26 | 2023-01-10 | Alkahest, Inc. | Methods of treating a subject for pain |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600832D0 (en) | Inhibitors of beta-amyloid protein production | |
| WO2004000387A3 (en) | Dialysis system for treatment of vulnerable patients and methods of use | |
| WO2005065383A3 (en) | Oxidative reductive potential water solution, processes for producing same and methods of using the same | |
| DE60317562D1 (de) | Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon | |
| UA35656C2 (uk) | Спосіб лікування безперервно прогредієнтних ослабоумлюючих психічних захворювань | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
| WO2005002526A3 (en) | Method and compositions for treatment of viral infections | |
| DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
| MY135838A (en) | Methods for the treatment of mental disorders | |
| ATE435026T1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| MXPA03009849A (es) | Uso de azitromicina para la fabricacion de un medicamento para el tratamiento de enfermedades inflamatorias no infecciosas. | |
| UA27102C2 (uk) | Склад для стабілізації плазми крові у процесі пастеризації, спосіб пастеризації плазми крові і засіб для терапії препаратом плазми | |
| DE60032590D1 (de) | Methode zur behandlung von schizophrenie | |
| TW200510437A (en) | Phosphinane compound with immunomodulating activity | |
| ATE285773T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
| DE3787437D1 (de) | Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems. | |
| DK82892D0 (da) | Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner | |
| HUP0103660A2 (hu) | Mikróbaeredetű hialuronsavbontó enzimet tartalmazó gyógyászati készítmény | |
| WO2002017917A8 (en) | Manzamines for treatment of drug resistant infection | |
| AU4788696A (en) | New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds | |
| WO2006041838A3 (en) | Heparinoid compositions for treatment and prevention of dementia | |
| TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
| AU2396900A (en) | Treatment and prevention of hiv and other viral infections | |
| UA29106A (uk) | Спосіб лікування вібраційної хвороби |